基本信息 产品详情 公司简介 推荐产品
网站主页 RETREG1抗体 RETREG1抗体
  • RETREG1抗体—艾普蒂
  • RETREG1抗体—艾普蒂
  • RETREG1抗体—艾普蒂

1/3

RETREG1抗体—艾普蒂

Rabbit Polyclonal RETREG1 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
上海 更新日期:2025-05-21

上海切尔齐生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:ruihening88@163.com

产品详情:

中文名称:
RETREG1抗体
英文名称:
Rabbit Polyclonal RETREG1 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 5280 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
RETREG1

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/300 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesJK1; JK-1; FAM134B
WB Predicted band size55 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human RETREG1
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Human heart tissue lysate, Primary antibody: P10091(RETREG1 Antibody) at dilution 1/400, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 7 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P10091(RETREG1 Antibody) at dilution 1/60. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P10091(RETREG1 Antibody) at dilution 1/60. (Original magnification: ×200)    


           

参考文献

以下是关于RETREG1(FAM134B)抗体的3篇代表性文献,涵盖其功能及疾病关联研究:

1. **文献名称**:*Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathies*

**作者**:Kurth, I. et al. (2009)

**摘要**:该研究首次发现FAM134B(RETREG1)基因突变与遗传性感觉和自主神经病变(HSAN)相关,通过免疫组化证实RETREG1抗体在神经元中的定位,提示其在维持神经细胞存活中的作用。

2. **文献名称**:*FAM134B oligomerization drives endoplasmic reticulum membrane scission for ER-phagy*

**作者**:Khaminets, A. et al. (2015)

**摘要**:研究利用RETREG1抗体通过免疫印迹和免疫荧光技术,揭示FAM134B通过形成寡聚体介导内质网自噬(ER-phagy),调控细胞器质量控制的分子机制。

3. **文献名称**:*FAM134B promotes cell proliferation in esophageal squamous cell carcinoma via activation of the Wnt/β-catenin signaling pathway*

**作者**:Liang, Y. et al. (2020)

**摘要**:通过Western blot和免疫组化分析,发现RETREG1在食管癌中高表达,并激活Wnt通路促进肿瘤生长,提示其作为潜在治疗靶点。

以上文献均使用RETREG1抗体进行蛋白表达或定位分析,涉及神经疾病、细胞自噬及癌症机制研究。如需更多细节,建议通过PubMed或Google Scholar按标题检索全文。

       

背景信息

The RETREG1 (reticulophagy regulator 1) antibody is a tool used to study the RETREG1 protein, also known as FAM134B, which plays a critical role in regulating endoplasmic reticulum (ER) homeostasis. RETREG1 is an ER-phagy receptor that facilitates selective autophagy of damaged ER fragments, a process termed "reticulophagy." It interacts with LC3/GABARAP proteins to mediate ER degradation, maintaining cellular health under stress conditions. Mutations in the RETREG1 gene are linked to hereditary sensory and autonomic neuropathy type II (HSAN-II), a disorder characterized by peripheral nerve degeneration, highlighting its importance in neuronal survival. Dysregulation of RETREG1 has also been implicated in cancers, including esophageal squamous cell carcinoma, where it may influence tumor progression via ER stress pathways.

RETREG1 antibodies are widely used in techniques like Western blotting, immunofluorescence, and immunohistochemistry to detect protein expression, localization, and dynamics in cellular and tissue models. These antibodies help elucidate RETREG1's role in ER quality control, autophagy, and disease mechanisms. Validated antibodies are essential for ensuring specificity, given potential cross-reactivity with homologous proteins. Research utilizing RETREG1 antibodies has advanced understanding of ER-phagy pathways and their therapeutic potential in neurodegenerative diseases and cancer.

       
RETREG1抗体;RETREG1;RETREG1 Antibody;

公司简介

是一家科研、开发、生产和销售为一体的科技型企业,

成立日期 (2年)
注册资本 20万人民币
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 抗体,蛋白组学,细胞生物学

RETREG1抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价